Role of the MDR-1-encoded multiple drug resistance phenotype in prostate cancer cell lines

Journal of Urology

Volumn 150, Issue 5 I, 1993, Pages 1544-1547

  Theyer, G ^a   Schirmbock, M ^a   Thalhammer, T ^a   Sherwood, E R ^a   Baumgartner, G ^a   Hamilton, G ^a  

^a WILHELMINEN HOSPITAL   (Austria)

Author keywords

doxorubicin; drug resistance; glycoproteins; prostate neoplasms; verapamil

Indexed keywords

CYCLOSPORIN A; DOXORUBICIN; GLYCOPROTEIN P; TAMOXIFEN; VERAPAMIL;

ARTICLE; CANCER CHEMOTHERAPY; CANCER RESISTANCE; DRUG CYTOTOXICITY; DRUG TRANSPORT; HUMAN; HUMAN CELL; MALE; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; PROSTATE CANCER;

EID: 0027739461     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(17)35838-X     Document Type: Article

References (17)

1. E. Silverberg C.C. Boring T.S. Squires Cancer statistics. CA Cancer J. Clin. 40 1990
2. C.S. Foster F.K. Mostofi Prostate cancer Human Pathol. 23 1992 211
3. C. Mahler L. Denis Management of relapsing disease in prostate cancer Cancer 70 1992 329
4. N.H. Slack G.P. Murphy A decade of experience with chemotherapy for prostate cancer Urology 22 1983 1
5. V. Ling P-glycoprotein and resistance to anticancer drugs Cancer 69 1992 2603
6. P. Van der Valk C.K. van Kalken H. Ketelaars J. Broxterman G. Scheffer T. Tsuruo J. Lankelma C.J. Meijer H.M. Pinedo Distribution of multi-drug resistance-associated P-glycoprotein in normal and neoplastic human tissues. Analysis with 3 monoclonal antibodies recognizing different epitopes of the P-glycoprotein molecule Ann. Oncol. 1 1990 56
7. M.E. Kaighn K.S. Narayan Y. Ohnuki J.F. Lechner L.W. Jones Establishment and characterization of a human prostatic carcinoma cell line (PC-3) Invest. Urology 17 1979 16
8. K.R. Stone D.D. Mickey H. Wunderli G.H. Mickey D.F. Paulson Isolation of a human prostate carcinoma cell line (DU145) Int. J. Cancer 21 1978 274
9. J.S. Horoszewicz S.S. Leong E. Kawinski J.P. Karr H. Rosenthal T. Ming Chu E.A. Mirand G.P. Murphy LNCaP: model of human prostatic carcinoma Cancer Res. 43 1983 1809
10. M. Pinto S. Robine-Leon M.D. Appay M. Kedinger N. Triadou E. Dussaulx B. Lacroix P. Simon-Assmann K. Haffen J. Fogh A. Zweibaum Enterocyte-like differentiation and polarization of the human colon carcinoma cell line CaCo-2 in culture Biol. Cell. 47 1983 323
11. A.A. Neyfakh Use of fluorescent dyes as molecular probes for the study of multidrug resistance Exp. Cell Res. 174 1988 168
12. C.R. Fairchild S.P. Ivy T. Rushmore G. Lee P. Koo M.E. Gold smith E. Färber K.H. Cowan Carcinogen-induced mdr overexpression is associated with xenobiotic resistance in rat preneoplastic liver nodules and hepatocellular carcinomas Proc. Natl. Acad. Sci. U. S. A. 84 1987 7701
13. R. Nemoto K. Hattori K. Uchida T. Shimazui Y. Nishijima K. Koiso M. Harada S-phase fraction of human prostate adenocarcinoma studied with in vivo bromodesoxyuridine labeling Cancer 66 1990 509
14. C.P.J. Vendrik J.J. Bergers W.D. De Jong P.A. Steerenberg Resistance to cytostatic drugs at the cellular level Cancer Chemother. Pharmacol. 29 1992 413
15. C.E. Herzog J.B. Trepel L.A. Mickeley S.E. Bates A.T. Fojo Various methods of analysis of mdr-1/P-glycoprotein in human colon cancer cell lines J. Natl. Cancer Inst. 84 1992 711
16. E. Berman M. Adams R. Duigou-Osterndorf L. Godfrey B. Clarkson M. Andreef Effect of tamoxifen on cell lines displaying the multidrug-resistant phenotype Blood 77 1991 818
17. J.M. Ford W.N. Hait Pharmacology of drugs that alter multidrug resistance in cancer Pharmacol. Rev. 42 1990 155